Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

This is a 6-month study to evaluate the effects of monotherapy with rivoglitazone, an insulin sensitizer, on glycemic control in newly identified type 2 diabetics or diabetics not adequately treated with other antidiabetic agents. The study tests rivoglitazone and uses a placebo and active treatment group for comparison.

Key facts

Study ID

NCT00143520

Run by

Daiichi Sankyo

People needed

441

Starts

2004-12-01

Expected to finish

2005-12-01

Last updated by the study team

2021-05-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes in male or female patients
• Between 18 and 75 years of age
• With a HbA1c greater than or equal to 7.5% and less than 10.5% at randomization

You may not qualify if…

• Type 1 diabetics or type 2 diabetics currently on insulin therapy
• Patients unwilling or unable to discontinue their anti-diabetic medication(s)
• History of ketoacidosis
• History of therapy with rosiglitazone, troglitazone, pioglitazone

Where it is running

• Study site — Columbiana, Alabama, United States
• Study site — Huntsville, Alabama, United States
• Study site — Muscle Shoals, Alabama, United States
• Study site — Hot Springs, Arkansas, United States
• Study site — Jonesboro, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Searcy, Arkansas, United States
• Study site — Sherwood, Arkansas, United States
• Study site — Los Angeles, California, United States
• Study site — Moreno Valley, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Mateo, California, United States
• Study site — Santa Monica, California, United States
• Study site — Torrance, California, United States
• Study site — Vista, California, United States
• Study site — West Hills, California, United States
• Study site — Newark, Delaware, United States
• Study site — Clearwater, Florida, United States
• Study site — Cocoa Beach, Florida, United States
• Study site — Jupiter, Florida, United States
• Study site — Largo, Florida, United States
• Study site — Miami, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.